Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:1295-1299

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frustaci, A.
Right arrow Articles by Maseri, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frustaci, A.
Right arrow Articles by Maseri, A.
Related Collections
Right arrow Other heart failure
Right arrow Myocardial cardiomyopathy disease
Right arrow Valvular heart disease

(Circulation. 1999;99:1295-1299.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Global Biventricular Dysfunction in Patients With Asymptomatic Coronary Artery Disease May Be Caused by Myocarditis

Andrea Frustaci, MD; Cristina Chimenti, MD; Attilio Maseri, MD

From the Cardiology Institute, Catholic University, Rome, Italy.

Correspondence to Andrea Frustaci, MD, Istituto di Cardiologia, Università Cattolica del Sacro Cuore, Largo Gemelli 8, 00168 Roma, Italy.

Background—The causal role of asymptomatic critical coronary artery obstruction in patients presenting with severe global biventricular dysfunction but no evidence of myocardial infarction is uncertain.

Methods and Results—Among 291 patients aged >40 years undergoing a noninvasive (2-dimensional echocardiography) and invasive (catheterization, coronary angiography, and biventricular endomyocardial biopsy, 6 to 8 samples/patient) cardiac study because of progressive heart failure (New York Heart Association functional class III or IV) with global biventricular dysfunction and no history of myocardial ischemic events, 7 patients (2.4%; 7 men; mean age, 49±6.9 years) had severe coronary artery disease (3 vessels in 4 patients; 2 vessels in 1 patient, proximal occlusion of left anterior descending coronary artery in 2 patients). Left ventricular end-diastolic diameter and ejection fraction by 2-dimensional echocardiography were 73±10.5 mm and 23±6.5%, respectively, and right ventricular end-diastolic diameter and ejection fraction were 39±7 mm and 29±7.2%, respectively. Biopsy specimens showed extensive lymphocytic infiltrates with focal myocytolysis meeting the Dallas criteria for myocarditis in all patients (in 5 patients with and 2 patients without fibrosis). Cardiac autoantibodies were detected with indirect immunofluorescence in the serum of 2 patients with active myocarditis. The 2 patients with active inflammation received prednisone (1 mg · kg-1 · d-1 for 4 weeks followed by 0.33 mg · kg-1 · d-1 for 5 months) and azathioprine (2 mg · kg-1 · d-1 for 5 months) in addition to conventional drug therapy for heart failure. At 8-month overall follow-up, cardiac volume and function improved considerably in immunosuppressed patients but remained unchanged in conventionally treated patients, of whom 1 died.

Conclusions—Global biventricular dysfunction in patients with severe asymptomatic coronary artery disease and no evidence of previous myocardial infarction may be caused by myocarditis. Histologic findings may influence the treatment.


Key Words: myocarditis • coronary disease • heart failure




This article has been cited by other articles:


Home page
HeartHome page
A Abbate, R Bussani, G Liuzzo, G G L Biondi-Zoccai, E Barresi, P Mellone, G Sinagra, A Dobrina, F De Giorgio, R Sharma, et al.
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation
Heart, June 1, 2008; 94(6): 737 - 742.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. De Cobelli, M. Pieroni, A. Esposito, C. Chimenti, E. Belloni, R. Mellone, T. Canu, G. Perseghin, C. Gaudio, A. Maseri, et al.
Delayed Gadolinium-Enhanced Cardiac Magnetic Resonance in Patients With Chronic Myocarditis Presenting With Heart Failure or Recurrent Arrhythmias
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1649 - 1654.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Chimenti, M. Pieroni, A. Frustaci, A. Abbate, F. Pandolfi, and F. Crea
Letter Regarding Article by Abbate et al, "Widespread Myocardial Inflammation and Infarct-Related Artery Patency" * Response
Circulation, January 18, 2005; 111(2): e17 - e17.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
A. Frustaci, M. Pieroni, and C. Chimenti
Immunosuppressive therapy in inflammatory cardiomyopathy
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I69 - I72.
[Abstract] [PDF]


Home page
ChestHome page
A. Frustaci, F. Calabrese, C. Chimenti, M. Pieroni, G. Thiene, and A. Maseri
Lone Hepatitis C Virus Myocarditis Responsive to Immunosuppressive Therapy
Chest, October 1, 2002; 122(4): 1348 - 1356.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Frustaci, L. Cuoco, C. Chimenti, M. Pieroni, G. Fioravanti, N. Gentiloni, A. Maseri, and G. Gasbarrini
Celiac Disease Associated With Autoimmune Myocarditis
Circulation, June 4, 2002; 105(22): 2611 - 2618.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Frustaci, C. Chimenti, M. Pieroni, and N. Gentiloni
Giant Cell Myocarditis Responding to Immunosuppressive Therapy
Chest, March 1, 2000; 117(3): 905 - 907.
[Abstract] [Full Text] [PDF]